Powder: -20°C for 3 years | In solvent: -80°C for 1 year
Darglitazone (CP-86325) is a potent, selective agonist of PPAR-γ with antidiabetic actions. Darglitazone is effective in controlling blood glucose and lipid metabolism.
Pack Size | Availability | Price/USD | Quantity |
---|---|---|---|
1 mg | In stock | $ 38.00 | |
2 mg | In stock | $ 54.00 | |
5 mg | In stock | $ 89.00 | |
10 mg | In stock | $ 147.00 | |
25 mg | In stock | $ 248.00 | |
50 mg | In stock | $ 369.00 | |
100 mg | In stock | $ 543.00 |
Description | Darglitazone (CP-86325) is a potent, selective agonist of PPAR-γ with antidiabetic actions. Darglitazone is effective in controlling blood glucose and lipid metabolism. |
In vitro | In cell lines representing white (3T3-L1 and 3T3-F442A) and brown (HIB-1B) adipose tissues and skeletal muscle (L6), Darglitazone(30 μM) stimulated the expression of UCP2 gene probably via PPAR-γ and increased uncoupling protein 2 (UCP2) mRNA[1]. |
In vivo | In male diabetic ob/ob mice, Darglitazone dramatically reduces the infarct size in the ob/ob mice at 24?h of recovery. Normalized blood glucose and reduced circulating triglycerides (TG) and very-low-density lipoproteins (VLDL) in diabetic ob/ob mice without having any effect in the nondiabetic mice. Darglitazone treatment restores acute cerebral inflammatory responses that were absent in the diabetic mice and profoundly improved their recovery from hypoxic-ischemic (H/I) insult[2]. |
Synonyms | CP-86325 |
Molecular Weight | 420.48 |
Formula | C23H20N2O4S |
CAS No. | 141200-24-0 |
Powder: -20°C for 3 years | In solvent: -80°C for 1 year
DMSO: 20mg/ml
Ethanol: ≤ 5 mg/mL
You can also refer to dose conversion for different animals. More
bottom
Please see Inhibitor Handling Instructions for more frequently ask questions. Topics include: how to prepare stock solutions, how to store products, and cautions on cell-based assays & animal experiments, etc.
Darglitazone 141200-24-0 DNA Damage/DNA Repair Metabolism PPAR oral UCP2 corticosterone CP-86325 PPAR-γ Diabetes CP86325 Inhibitor inhibit Peroxisome proliferator-activated receptors thiazolidinedione CP 86325 inhibitor